India Drug Makers Weigh Suit Against Ban On Selling Drugs By Brand
This article was originally published in PharmAsia News
India's drug makers are considering taking legal action against the health ministry's action to ban the marketing of drugs under their brand names, requiring generic references only.
You may also be interested in...
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.